The Cryonics Industry Would Like to Give You the Past Year, and Many More, Back
The business of cryopreservation — storing bodies at deep freeze until well into the future — got a whole lot more complicated during the pandemic.
When an 87-year-old Californian man was wheeled into an operating room just outside Phoenix last year, the pandemic was at its height and medical protocols were being upended across the country.
Had he been infected with the coronavirus, tiny aerosol droplets could have escaped and infected staff, so the operating team had adopted new procedures that reduced the effectiveness of the treatment but used fewer liquids.
He had arrived in the operating room of Alcor Life Extension Foundation — located in an industrial park near the airport in Scottsdale, Ariz. — packed in dry ice and ready to be “cryopreserved,” or stored at deep-freeze temperatures, in the hope that one day, perhaps decades or centuries from now, he could be brought back to life.
From Moscow to Phoenix and from China to rural Australia, the major players in the business of preserving bodies at extremely low temperatures say the pandemic has brought new stresses to an industry that has long faced skepticism or outright hostility from medical and legal establishments that have dismissed it as quack science or fraud.
